The Drug Enforcement Administration (DEA) requires the relocation of equipment to Intrepid for evidence analysis. The DEA intends to award a firm-fixed price sole source Purchase Order to Agilent Technologies, Inc., 2850 Centerville Rd., Wilmington, DE 19808-1610 for the purposes of relocating equipment to Intrepid for evidence analysis. This acquisition is being pursued on a sole source basis in accordance with 41 U.S.C. 3304(a)(1) are exempt from the requirement to promote full and open competition. The NAICS code for this acquisition is 334516. A determination by the Government not to open the requirement to competition based on the response to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. This notice is NOT a request for proposal. However, all capability statements received by June 15, 2026 at 9:00 a.m. EST will be considered by the Government. Any source capable of providing the relocation of equipment to Intrepid for evidence analysis, and is interested in submitting a capabilities statement may do so electronically to Ms. Angel Barkley at angel.d.barkley@dea.gov.